Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A total of 100 patients with ST-elevation myocardial infarction (STEMI) presenting slow-flow after primary-percutaneous coronary intervention (PPCI) will be randomized to pharmacologic treatment with hyperemic drugs versus flow-mediated hyperemia.
Epistemonikos ID: c0228d51341e4c8451af3435068f096afeb93182
First added on: May 08, 2024